论文部分内容阅读
目的:本文就顺尔宁治疗支气管哮喘的临床效果进行了浅显的研究和探讨。方法:将我院自2013年1月-2014年1月期间收治的49例哮喘非急性发作患者分成治疗组及对照组,均予以沙丁胺醇治疗,治疗组加用顺尔宁治疗,对两组患者接受用药治疗前后的临床症状、肺功能及表面激素应用量等指标的改善情况进行观察和统计。结果:治疗组患者接受治疗前后临床症状、肺功能改善情况以及表面激素应用量改善程度明显优于对照组患者(P<0.05)。结论:顺尔宁应用于支气管哮喘临床治疗中的效果显著,有效改善了患者的临床症状,值得推广。
Objective: In this paper, the clinical effect of treatment of bronchial asthma with a brief study and discussion. METHODS: Forty-nine patients with non-acute exacerbation of asthma who were admitted to our hospital from January 2013 to January 2014 were divided into treatment group and control group, all of which were treated with salbutamol. The treatment group was treated with cisplatin, and the patients in both groups Before and after treatment with clinical symptoms, pulmonary function and the application of surface hormones and other indicators of improvement were observed and statistics. Results: The improvement of clinical symptoms, pulmonary function and surface hormone application in treatment group were better than those in control group before and after treatment (P <0.05). Conclusion: The effect of Xundianning in the clinical treatment of bronchial asthma is significant, which effectively improves the clinical symptoms of patients and is worth promoting.